Lurz, P, Coats L, Khambadkone S, et al. Percutaneous pulmonary valve implantation: impact of evolving technology and learning curve on clinical outcome. Circulation
2008; 117: 1964–1972.
Lurz, P, Gaudin R, Taylor AM, Bonhoeffer P. Percutaneous pulmonary valve implantation. Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu
McElhinney, DB, Hellenbrand WE, Zahn EM, et al. Short- and medium-term outcomes after transcatheter pulmonary valve placement in the expanded multicenter US melody valve trial. Circulation
2010; 122: 507–516.
Zahn, EM, Hellenbrand WE, Lock JE, McElhinney DB. Implantation of the melody transcatheter pulmonary valve in patients with a dysfunctional right ventricular outflow tract conduit early results from the U.S. clinical trial. J Am Coll Cardiol
2009; 54: 1722–1729.
Gurtcheff, SE. Introduction to the MAUDE database. Clin Obstet Gynecol
2008; 51: 120–123.
Taggart, NW, Connolly, HM, Hagler, DJ. Acute heart failure after percutaneous pulmonary valve (melody(copyright) valve) implantation. Catheter Cardiovasc Interv
2011; 77: S139–S140.
Taggart, NW, Hagler, DJ, Connolly, HM. Melody valve erosion into the ascending aorta. Congenit Heart Dis
2013; 8: E64.
Peer, SM, Sinha, P. Percutaneous pulmonary valve implantation after Ross-Konno aortoventriculoplasty: a cautionary word. J Thorac Cardiovasc Surg
2014; 147: e74–e75.
Biermann, D, Schonebeck J, Rebel M, Weil J, Reichenspurner H, Dodge-Khatami A. Coronary event after transcatheter pulmonary valve implantation. Thorac Cardiovasc Surg
2012; 94: e7–e9.
Dehghani, P, Kraushaar, G, Taylor, DA. Coronary artery compression three months after transcatheter pulmonary valve implantation. Catheter Cardiovasc Interv
2015; 851: 611–614.
Berman, DP, McElhinney DB, Vincent JA, Hellenbrand WE, Zahn EM. Feasibility and short-term outcomes of percutaneous transcatheter pulmonary valve replacement in small (<30 kg) children with dysfunctional right ventricular outflow tract conduits. Circ Cardiovasc Interv
2014; 7: 142–148.
Armstrong, AK, Balzer DT, Cabalka AK, et al. One-year follow-up of the Melody transcatheter pulmonary valve multicenter post-approval study. JACC Cardiovasc Interv
2014; 7: 1254–1262.
Bishnoi, RN, Jones TK, Kreutzer J, Ringel RE. NuMED Covered Cheatham-Platinum Stent for the treatment or prevention of right ventricular outflow tract conduit disruption during transcatheter pulmonary valve replacement. Catheter Cardiovasc Interv
2015; 85: 421–427.
McElhinney, DB, Benson LN, Eicken A, Kreutzer J, Padera RF, Zahn EM. Infective endocarditis after transcatheter pulmonary valve replacement using the melody valve: combined results of 3 prospective North American and European studies. Circ Cardiovasc Interv
2013; 6: 292–300.
McElhinney, DB, Cheatham JP, Jones TK, et al. Stent fracture, valve dysfunction, and right ventricular outflow tract reintervention after transcatheter pulmonary valve implantation: patient-related and procedural risk factors in the US melody valve trial. Circ Cardiovasc Interv
2011; 4: 602–614.
DiBardino, DJ, McElhinney DB, Kaza AK, Mayer JE, Jr. Analysis of the US Food and Drug Administration manufacturer and user facility device experience database for adverse events involving Amplatzer septal occluder devices and comparison with the Society of Thoracic Surgery Congenital Cardiac Surgery database. J Thorac Cardiovasc Surg
2009; 137: 1334–1341.
Lenzer, J, Brownlee, S. Why the FDA can’t protect the public. BMJ
2010; 341: c4753.
Van Dijck, I, Budts W, Cools B, et al. Infective endocarditis of a transcatheter pulmonary valve in comparison with surgical implants. Heart
2015; 101: 788–793.
Buber, J, Bergersen L, Lock JE, et al. Bloodstream infections occurring in patients with percutaneously implanted bioprosthetic pulmonary valve: a single-center experience. Circ Cardiovasc Interv
2013; 6: 301–310.
Sutherell, JS, Hirsch, R, Beekman, RH 3rd. Pediatric interventional cardiology in the United States is dependent on the off-label use of medical devices. Congenit Heart Dis
2010; 5: 2–7.
Torres, A, Sanders SP, Vincent JA, et al. Iatrogenic aortopulmonary communications after transcatheter interventions on the right ventricular outflow tract or pulmonary artery: pathophysiologic, diagnostic, and management considerations. Catheter Cardiovasc Interv
2015; 86: 438–452.